Cochlear implants are neural-implants that restore auditory perception in individuals with severe-to-profound sensorineural hearing loss by directly stimulating the auditory nerve. An external sound processor captures and digitizes acoustic signals, converts them into electrical stimulation patterns, and transmits these patterns wirelessly to a surgically implanted receiver-stimulator coupled to an electrode array threaded into the cochlea. By bypassing damaged or absent hair cells, the device delivers tonotopically organized electrical pulses to spiral ganglion neurons, enabling recipients to perceive sound.

Since their clinical introduction in the 1980s, cochlear implants have become the most successful neuroprosthetics-and-rehabilitation device in history, with over one million recipients worldwide. Modern systems use multi-channel electrode arrays (typically 12–22 contacts) and sophisticated signal processing strategies — including continuous interleaved sampling (CIS), spectral peak (SPEAK), and advanced combinational encoder (ACE) — to maximize speech intelligibility. Bilateral implantation and combined electric-acoustic stimulation in ears with residual low-frequency hearing have further expanded candidacy and outcomes.

Key ongoing challenges include improving music perception and tonal language recognition, refining electrode-nerve interfaces to reduce channel interaction and current spread, achieving closer coupling with surviving neural elements through pharmacological or genetic therapies, and extending candidacy to populations with auditory neuropathy or central hearing loss. Integration of machine learning for adaptive sound processing and fully implantable designs without external components represent active areas of research and development.